| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-19 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.45 | 6e-13 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-12 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.32 | 2e-11 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.4 | 2e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.38 | 6e-08 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |